Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma
- 15 July 1997
- Vol. 80 (2) , 242-249
- https://doi.org/10.1002/(sici)1097-0142(19970715)80:2<242::aid-cncr12>3.0.co;2-u
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomasCancer, 1996
- Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis.Proceedings of the National Academy of Sciences, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- The retinoblastoma gene is involved in malignant progression of astrocytomasAnnals of Neurology, 1994
- Prognostic factors in gliomas. A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markersCancer, 1994
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- Resection, biopsy, and survival in malignant glial neoplasmsJournal of Neurosurgery, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Wild-type p53 is a cell cycle checkpoint determinant following irradiation.Proceedings of the National Academy of Sciences, 1992
- Supratentorial anaplastic gliomas in adultsJournal of Neurosurgery, 1989